Literature DB >> 15458844

The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin.

Guido Meyer1, Frederique Varoqueaux, Antje Neeb, Melanie Oschlies, Nils Brose.   

Abstract

The postsynaptic specialisation at glutamatergic synapses is composed of a network of proteins located within the membrane and the underlying postsynaptic density. The strong interconnectivity between the protein components is mediated by a limited number of interaction modes. Particularly abundant are PDZ domain-mediated interactions. An obstacle in understanding the fidelity of postsynaptic processes involving PDZ domains is the high degree of overlap with respect to their binding specificities. Focussing on transsynaptic adhesion molecules, we used the yeast two-hybrid system to obtain an overview of the binding specificities of selected C-terminal PDZ binding motifs. Neuroligin, a postsynaptic cell surface protein that spans the synaptic cleft and interacts with beta-neurexin, served as a starting point. Neuroligin binds to the PDZ domain-containing proteins PSD95, SAP102, Chapsyn110, S-SCAM, Magi1 and 3, Shank1 and 3, Pick1, GOPC, SPAR, Semcap3 and PDZ-RGS3. Next, we examined the relationship between neuroligin and synaptic cell adhesion molecules or glutamate receptor subunits with respect to PDZ-mediated interactions. We found a limited overlap in the PDZ-domain binding specificities of neuroligin with those of Sidekick2 and Ephrin-B2. In contrast, Syndecan2 and IgSF4 show no overlap with the PDZ-domain specificity of neuroligin, instead, they bind to GRIP and syntenin. The AMPA receptor subunit GluR2 interacts with Semcap3 and PDZ-RGS3, whereas the kainate receptor subunits GluR5 and GluR6 show weak interactions with PSD95. In summary, we can sketch a complex pattern of overlap in the binding specificities of synaptic cell surface proteins towards PDZ-domain proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15458844     DOI: 10.1016/j.neuropharm.2004.06.023

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  78 in total

1.  PICK1 mediates synaptic recruitment of AMPA receptors at neurexin-induced postsynaptic sites.

Authors:  Junyu Xu; Chuen Kam; Jian-Hong Luo; Jun Xia
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  Associating neural alterations and genotype in autism and fragile x syndrome: incorporating perceptual phenotypes in causal modeling.

Authors:  Armando Bertone; Julie Hanck; Cary Kogan; Avi Chaudhuri; Kim Cornish
Journal:  J Autism Dev Disord       Date:  2010-12

Review 3.  Organization of central synapses by adhesion molecules.

Authors:  Alexandra Tallafuss; John R L Constable; Philip Washbourne
Journal:  Eur J Neurosci       Date:  2010-07-14       Impact factor: 3.386

4.  An Autism-Associated Mutation Impairs Neuroligin-4 Glycosylation and Enhances Excitatory Synaptic Transmission in Human Neurons.

Authors:  Thomas P Cast; Daniel J Boesch; Kim Smyth; Alisa E Shaw; Michael Ghebrial; Soham Chanda
Journal:  J Neurosci       Date:  2020-12-02       Impact factor: 6.167

5.  Solution structure of GOPC PDZ domain and its interaction with the C-terminal motif of neuroligin.

Authors:  Xiang Li; Jiahai Zhang; Zanxia Cao; Jihui Wu; Yunyu Shi
Journal:  Protein Sci       Date:  2006-08-01       Impact factor: 6.725

Review 6.  Bidirectional ephrin/Eph signaling in synaptic functions.

Authors:  Jason Aoto; Lu Chen
Journal:  Brain Res       Date:  2006-12-12       Impact factor: 3.252

Review 7.  Neurexin-neuroligin signaling in synapse development.

Authors:  Ann Marie Craig; Yunhee Kang
Journal:  Curr Opin Neurobiol       Date:  2007-02-01       Impact factor: 6.627

8.  Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.

Authors:  Christelle M Durand; Catalina Betancur; Tobias M Boeckers; Juergen Bockmann; Pauline Chaste; Fabien Fauchereau; Gudrun Nygren; Maria Rastam; I Carina Gillberg; Henrik Anckarsäter; Eili Sponheim; Hany Goubran-Botros; Richard Delorme; Nadia Chabane; Marie-Christine Mouren-Simeoni; Philippe de Mas; Eric Bieth; Bernadette Rogé; Delphine Héron; Lydie Burglen; Christopher Gillberg; Marion Leboyer; Thomas Bourgeron
Journal:  Nat Genet       Date:  2006-12-17       Impact factor: 38.330

9.  Contribution of SHANK3 mutations to autism spectrum disorder.

Authors:  Rainald Moessner; Christian R Marshall; James S Sutcliffe; Jennifer Skaug; Dalila Pinto; John Vincent; Lonnie Zwaigenbaum; Bridget Fernandez; Wendy Roberts; Peter Szatmari; Stephen W Scherer
Journal:  Am J Hum Genet       Date:  2007-10-16       Impact factor: 11.025

10.  Pathogenesis of autism: a patchwork of genetic causes.

Authors:  Elena L Grigorenko
Journal:  Future Neurol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.